Search results
Results from the WOW.Com Content Network
Tardive dyskinesia ( TD) is a disorder that results in involuntary repetitive body movements, which may include grimacing, sticking out the tongue or smacking the lips. [1] Additionally, there may be chorea or slow writhing movements. [1] In about 20% of people with TD, the disorder interferes with daily functioning. [3]
Early years and high school career. Edwards was born in 2003 in West Bloomfield, Michigan, the son of Kevin and Donna Edwards. His mother, Donna, died from cancer in 2005 when Donovan was two years old.
Pantothenate kinase-associated neurodegeneration (PKAN), formerly called Hallervorden–Spatz syndrome, is a genetic degenerative disease of the brain that can lead to parkinsonism, dystonia, dementia, and ultimately death.
Transfusion-dependent anemia is a form of anemia characterized by the need for continuous blood transfusion. It is a condition that results from various diseases, and is associated with decreased survival rates. [1] [2] Regular transfusion is required to reduce the symptoms of anemia by increasing functional red blood cells and hemoglobin count ...
The symptoms of an ataxia vary with the specific type and with the individual patient. In many cases a person with ataxia retains full mental capacity but progressively loses physical control. [citation needed] Cause. The hereditary ataxias are categorized by mode of inheritance and causative gene or chromosomal locus.
European Inventor Award 2011. Scientific career. Fields. Orthopedic surgery. Institutions. Gothenburg University. Per-Ingvar Brånemark (3 May 1929 – 30 December 2014) was a Swedish physician and researcher, known as the "father of modern dental implantology ". [1] The Brånemark Osseointegration Center (BOC), named after its founder, was ...
She and Stephen Teap, a fellow campaigner, founded the 221+ CervicalCheck patient group for women who had also received negative tests but were later diagnosed with cancer. Phelan was awarded an honorary doctorate from UL in June 2018 for her contribution to women's health.
The ED50 is commonly used as a measure of the reasonable expectancy of a drug effect, but does not necessarily represent the dose that a clinician might use. This depends on the need for the effect, and also the toxicity. The toxicity and even the lethality of a drug can be quantified by the TD 50 and LD 50 respectively. Ideally, the effective ...